The number of infections caused by Staphylococcus aureus has increased dramatically during the past 20 years. Patients undergoing major surgery are at high risk for surgical site infection (SSI) and bloodstream infection (BSI) due to S. aureus. [1] [2] [3] [4] [5] [6] [7] These S. aureus postsurgical infections are associated with increased mortality, length of hospitalization, and cost of care. [8] [9] [10] [11] [12] [13] Surprisingly, the epidemiological characteristics of S. aureus postsurgical infections remain incompletely understood. Previous studies on the burden of postoperative S. aureus infections have been limited to single procedure types, single healthcare centers, tertiary care institutions, and/or only 1 type of postoperative infection (typically SSI). Thus, the overall objective of this multicenter study was to compare the frequency and epidemiological characteristics of S. aureus SSI and BSI following 4 types of major surgical procedures in both tertiary and community hospitals.
methods

Study Design and Participating Centers
This multicenter retrospective cohort study combined preexisting, prospectively collected surgical surveillance data for SSI and microbiological data for BSI from 11 hospitals located in North Carolina and Virginia. Two surgical surveillance databases were used: the Duke Infection Control Outreach Network (DICON) surgical database and the Duke University Medical Center (DUMC) surgical database. Both of these surgical surveillance databases have been previously described and validated. 14, 15 These databases included operative variables, such as patient age, date of surgical procedure, type of procedure, and National Healthcare Safety Network (NHSN) risk index variables (ie, wound class, American Society of Anesthesiologists [ASA] score, and length of procedure). 16 For patients with SSI, the following data were obtained: type of SSI (ie, superficial incisional, deep incisional, or organ/space), causative pathogen, pathogen susceptibility to antibiotics, date of infection, and anatomic site of culture sampling. Patients who developed SSI after undergoing operations were prospectively identified and recorded in the DICON and DUMC surgical surveillance databases by using identical and standard surveillance definitions and methods from the Centers for Disease Control and Prevention (CDC). 17 BSI data were identified by querying study hospitals' microbiological databases for the following variables: patient medical record number, date of culture sampling, culture type ("blood"), pathogen(s), and pathogen susceptibilities to antibiotics. We identified patients who developed BSI after undergoing surgical procedures by electronically merging data from the surgical surveillance databases and the microbiological databases on the basis of the medical record number and dates of surgery and BSI. The study was approved by the institutional review boards at all participating hospitals.
Study Population
The study population consisted of all adult patients (aged at least 18 years) who underwent a major surgical procedure at a study hospital during the period from January 1, 2003, through December 31, 2006 . Major surgical procedures were defined as one of the following: specific cardiothoracic procedure (coronary artery bypass graft or prosthetic implant: cardiac valve replacement), neurosurgical procedure (insertion of prosthetic implants [ie, spinal fusion and ventricular shunt replacement], laminectomy, spinal fusion without implant, craniotomy, and other neurosurgical procedure), orthopedic procedure (insertion of prosthetic implants [ie, insertion of knee, hip, or other prosthesis]), open reduction internal fixation of a fracture, other musculoskeletal procedure, or amputation), or plastic surgical procedure (mastectomy, skin graft, or other plastic surgical procedure).
Outcome Variables
The primary outcome for the study, invasive S. aureus infection, was defined as invasive SSI and/or BSI due to S. aureus. Other study outcomes of interest included the methicillin susceptibility of the invasive S. aureus isolate and whether the infection was monomicrobial or polymicrobial.
Collectively, deep incisional and organ/space SSIs were defined as invasive SSIs. According to CDC definitions, 17 SSIs could be diagnosed within 1 year after the procedure for all procedures involving implantation of a prosthetic device; if no prosthetic device was implanted during the procedure, SSIs could be diagnosed within 30 days after the procedure. BSIs were defined with the use of modified CDC criteria: at least 1 positive blood culture result within 90 days after the surgical procedure for all pathogens except coagulase-negative staphylococci, micrococci, propionibacteria, diphtheroids, enterococci, viridans group streptococci, and bacilli, for which at least 2 positive results for cultures of blood collected during a 48-hour period were required. 18 We modified the CDC definition by including enterococci as a type of potential skin contaminant (ie, including it in the list of pathogens for which at least 2 positive blood culture results during a 48-hour period were required) to reduce the effect of contaminants on our results. 19, 20 
Statistical Analysis
Patients could undergo multiple major surgical procedures during the study period. Infections were attributed to the patients' most recently performed surgical procedure. Patients' procedures were excluded from the analyses for the following reasons: (1) their procedures were identified as belonging to a dirty or infected wound class; (2) their procedures were performed after documentation of their first S. aureus infection; however, patients were included if they had both an S. aureus BSI and an S. aureus SSI after the same procedure, as long as both infections met the study definitions described above; or (3) their procedures were associated with a superficial incisional S. aureus SSI or SSI of unknown type (ie, there was no information to distinguish between superficial SSI and invasive SSI).
A size cutoff of 500 beds was used to categorize each hospital as a community hospital (9 hospitals) or a tertiary care hospital (2 hospitals) ( cedures, and 1 hospital did not conduct SSI surveillance on plastic surgical procedures.
All statistical analyses were performed using SAS software, version 9.1 (SAS Institute). All statistical tests were 2 tailed, and a P value of less than .05 was considered to indicate a significant difference. Incidences were calculated as the number of infections per 100 surgical procedures. Nonparametric bootstrapping was used to generate 95% confidence intervals (CIs) for the incidences.
Among patients with infection, Kaplan-Meier analyses were performed to compute the median time between the date of the surgical procedure and the date of onset of infection and to make comparisons across procedure types. We used x 2 statistics to compare proportions of patients with infections due to methicillin-resistant S. aureus (MRSA) and patients with infections due to methicillin-susceptible S. aureus across types of surgical procedure. Patients whose S. aureus isolates lacked susceptibility data were excluded from analyses comparing MRSA and MSSA (8 patients with SSI and 11 patients with BSI). Bivariable comparisons were performed to evaluate which characteristics were associated with the development of invasive S. aureus infection by comparing patients who did with patients who did not develop an infection that met our endpoint definitions. Patients with a superficial S. aureus infection or an infection due to another pathogen were excluded from the uninfected patient comparison group. P values were calculated with the use of the Pearson x 2 test for categorical variables and the Student t test or the Wilcoxon rank-sum test for continuous variables (as indicated).
results
Overall Study Population
In total, 81,267 patients underwent 96,455 surgical procedures at 11 study hospitals during the 48-month study period; 11,955 patients (14.7%) underwent more than 1 major surgical procedure. The mean age ‫ע(‬ standard deviation) of the overall cohort at the time of each patient's first surgical procedure was 55 ‫ע‬ 17 years (range, 18-105 years). In total, 572 S. aureus infections and 497 non-S. aureus infections were identified during the study period. Of the 572 S. aureus infections, 102 superficial incisional SSIs and 16 SSIs of unknown type were subsequently excluded from the analysis. Thus, the final study cohort included 454 invasive S. aureus infections in 454 unique patients, which occurred after 96,455 surgical procedures (overall rate, 0. for trend). P p .09 Approximately one-half of the invasive S. aureus infections were due to MRSA (227 [51%] of 446 with susceptibility data); 147 (48%) of the 309 SSIs with susceptibility data were due to MRSA, whereas 107 (60%) of the 178 BSIs with susceptibility data were due to MRSA. Twenty-eight (6.2%) of the 454 invasive S. aureus infections, 24 (7.6%) of the 317 S. aureus SSIs, and 4 (2.1%) of the 188 S. aureus BSIs were polymicrobial.
The median time to onset of invasive S. aureus infection after surgery was 30 days (IQR, . The median time to onset of S. aureus SSI after surgery was 19 days (IQR, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] , whereas the time to onset of S. aureus BSI was 18 days (IQR, 10-44).
Patients with invasive S. aureus infections generally had higher NHSN risk index scores than did uninfected patients ( Table 1 ). The higher NHSN risk index scores were reflective of higher ASA scores and significantly longer durations of surgical procedures (typically more than 1 hour longer than for uninfected patients).
Invasive S. aureus Infection According to Type of Procedure
The majority of procedures included in the study cohort were orthopedic (57,748 [60%] of 96,455 procedures); there were fewer neurosurgical procedures (24, 135 [25%]), cardiothoracic procedures (9, 299 [10%]), and plastic surgical procedures (5,273 [5%] ). The highest rates of invasive S. aureus infection and S. aureus BSI occurred after cardiothoracic pro- (14) 79 (37) 5,750 (10) 35 (23) 3,761 (16) 33 (45) 3,577 (40) 2 (12) 252 (5) Missing 50 (11) 3,347 (4) 8 (4) 1,159 (2) 30 (20) 1,224 (5) 12 (16) 960 ( (32) 120 (56) 18,740 (33) 58 (39) 8,030 (34) 19 (26) 2,694 (30) 7 (41) 1,435 (28) x4 97 (21) 9,611 (10) 38 (18) 2,761 (5) 10 (7) 1,021 (4) 46 (63) 5,622 (62) 3 (18) 206 (4) Missing 39 (9) 2,120 (2) 3 (1) 588 (1) 29 (19) 949 (4) 7 (10) 583 ( 6,662 (7) 24 (11) 3,863 (7) 5 (3) 1,039 (4) 4 (5) 871 (10) 7 (41) 889 ( . Medium-volume hospitals had the lowest P p .41 incidence of invasive S. aureus infections, compared with both high-volume hospitals and low-volume hospitals (Figure 1 ).
When infection rates for specific types of procedures were compared, tertiary care hospitals had higher rates of invasive S. aureus infection after orthopedic, neurosurgical, and cardiothoracic procedures, compared with community hospitals (Table 2) . Medium-volume hospitals had lower rates of invasive S. aureus infection than did low-or high-volume hospitals for all 4 procedure types ( Table 2) .
Invasive S. aureus Infection after Major Procedures Involving Prosthetic Devices
Of the 22,442 procedures involving implantation of a prosthetic device, the majority were orthopedic (16, 549 [74%]), followed by neurosurgical (3,634 [16%] ) and cardiothoracic (2, 259 [10%]). The overall incidence of invasive S. aureus infection after major surgical procedures involving prosthetic devices was 0.70 infections per 100 procedures (95% CI, 0.59-0.81).
Rates of invasive S. aureus infection were similar across the 3 procedure types with prosthetic devices (Table 2) . Rates of infection after orthopedic and neurosurgical procedures were largely driven by higher rates of SSI; in contrast, the rate of invasive S. aureus infection after cardiothoracic procedures was almost entirely due to BSI.
More than half of the infections after placement of a prosthetic device (83 [54%] of 154) were caused by MRSA. MRSA caused 13 (87%) of 15 infections after cardiothoracic procedures involving implants but only 12 (40%) of 30 infections after neurosurgical procedures involving implants ( Table 2 ). The median time from surgery to onset of invasive infection due to S. aureus was 27 days (IQR, 17-47). The time to infection varied across the 3 types of surgical procedures (Table 2).
discussion
This multicenter study is one of the largest studies on invasive S. aureus infection after major surgical procedures to date and provides novel information regarding the epidemiological characteristics of invasive S. aureus infections. In contrast to previously published reports on postoperative S. aureus infection, our epidemiologic analysis included data on 2 types of postoperative infections (SSI and BSI) from different types of hospitals with varying volume of surgical procedures performed. To our knowledge, our analysis is the first to specifically compare the epidemiological characteristics of postoperative S. aureus infections following 4 specific procedure types.
Previously published studies have reported overall incidences of postoperative S. aureus infection of 0.8-1.3 infections per 100 procedures. 1, [21] [22] [23] [24] Other studies have reported incidences of S. aureus SSI of 0.4-11.6 infections per 100 procedures for cardiothoracic procedures 1, 7, [25] [26] [27] and 0.12-0.73 infections per 100 procedures for orthopedic procedures. [28] [29] [30] [31] The reported incidence of postoperative S. aureus BSI after cardiothoracic procedures is 0.60-1.09 infections per 100 procedures. 1, 7 Our results are generally consistent with these procedure-specific rates, although our overall rate of invasive S. aureus infection was lower than that of previously published reports. To our knowledge, no previously published studies have evaluated the rate of S. aureus SSI specifically for neurosurgical or plastic surgical procedures and no previously published reports have evaluated the postoperative rate of S. aureus BSI following orthopedic, neurosurgical, or plastic surgical procedures. Interstudy comparisons of procedure-specific rates, however, are limited by differences in study methods among different studies (eg, infection definitions, prospective or retrospective classification, distribution of proce- 6/17 (35) .03
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Time dure types, single-center or multicenter study, location, hospital type, and time period). Of note, no specific interventions (eg, screening using nasal samples or bathing with chlorhexidine gluconate) were routinely used at all study hospitals during the study period. The results of this report make a key point: the frequency and type of postoperative invasive S. aureus infection varied significantly across procedure types. Overall, invasive S. aureus infections were more common after cardiothoracic procedures than after orthopedic, neurosurgical, or plastic surgical procedures. Similarly, S. aureus BSI was most common after cardiothoracic procedures, comprising almost threequarters of the invasive S. aureus infections following this procedure type. By contrast, more than 80% of invasive S. aureus infections after neurosurgical procedures were SSIs.
Our results are consistent with previously published data that suggest that MRSA has emerged as the leading cause of invasive postoperative infections. 6, 29, 32 Overall, MRSA accounted for 51% of postoperative invasive S. aureus infections. Wide variability, however, was noted among the 4 procedure types. For example, MRSA accounted for 62% of S. aureus infections after cardiothoracic surgery but just 35% of S. aureus infections after plastic surgical procedures.
Our analysis also provides unique data regarding the time to onset of invasive S. aureus infection following the 4 specific surgical types. Previously published data suggest that most SSIs are detected within 3 weeks after surgery. 33, 34 Our overall data were consistent with this finding (median time to invasive S. aureus infection was 20 days), but we found wide variability for the 4 surgical types (eg, median time to invasive S. aureus infection was 14 days after plastic surgery, 24 days after orthopedic surgery, and 28 days after the insertion of orthopedic prosthetic devices).
Finally, differences were also noted in the rates of invasive S. aureus infection after stratifying according to hospital characteristics. Consistent with previously published data, the rate of invasive S. aureus infection was higher at tertiary care hospitals than at community hospitals. 35 Also consistent with previously published data, hospitals with high surgical volume or low surgical volume had higher rates of postoperative invasive S. aureus infection than hospitals with medium surgical volume. 36 We were unable to determine, however, whether specific differences in case mix among hospitals (eg, predominance of 1 type of procedure) led to the observed associations between surgical volume and rates of invasive S. aureus infection.
This study has limitations that likely lead to underestimates of the true incidence of invasive S. aureus infection after major surgical procedures. First, we excluded superficial incisional SSIs and other invasive infections (eg, pneumonia). Second, this study did not include data from patients who died before diagnosis of invasive infection or who sought care for postoperative infections at an institution other than the one where the surgical procedure took place. In addition, we were unable to identify the type of SSI (invasive or superficial incisional) for 16 patients with S. aureus SSI. However, even if all of these individuals had invasive S. aureus infection, the overall incidence would have increased by only 0.016 infections per 100 procedures. Next, we were not able to gather information specifically on the type of antimicrobial prophylaxis used prior to each surgical procedure. In addition, we were unable to determine the source of BSIs (eg, primary vs secondary). Finally, all of the 11 sites included in this study are situated in the southeastern United States.
Despite these limitations, we believe that this study provides novel information for clinicians regarding the epidemiological characteristics of S. aureus infections. Our study emphasizes that, with regard to the epidemiologial characteristics of S. aureus infections after different types of surgical procedures, one size does not fit all. Although 100% prevention of postoperative infection is likely impossible, we must continue to strive for better preventative interventions for our most deadly and costly infections. 
